Download PDF
Semin Reprod Med 2014; 32(06): 447-453
DOI: 10.1055/s-0034-1384628
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Prevention of Cardiovascular Disease in Women

Anthony A. Bavry
1   Department of Medicine, University of Florida, Gainesville, Florida
,
Marian C. Limacher
1   Department of Medicine, University of Florida, Gainesville, Florida
› Author Affiliations
Further Information

Publication History

Publication Date:
16 October 2014 (online)

    Permissions and Reprints

Abstract

Cardiovascular disease is the leading cause of death among women. In fact, the cardiovascular disease mortality rate among women exceeds the rate in men. Unfortunately, many minority women are still unaware of the importance of this disease. All women, including those with no history of cardiovascular disease, should have an accurate estimate of the probability of a cardiovascular disease event (death, myocardial infarction, or stroke) usually within the next decade. Such an estimate will help determine if women are candidates for preventive measures and specific therapies such as aspirin. Data from the Framingham Heart Study were used to construct a risk score, which is now widely used; however, other risk scores are available. To prevent cardiovascular disease, women should refrain from smoking, maintain a healthy weight, eat a heart-healthy diet, be physically active, and have normal blood pressure and cholesterol levels. Aspirin can be considered for primary prevention, with expected benefit to prevent ischemic stroke; however, this needs to be balanced against potential bleeding risk. Hormone therapy is no longer recommended due to an increase in adverse events (most consistently seen as increased ischemic stroke risk). Folic acid is also no longer recommended due to lack of benefit.

Keywords

aspirin - primary prevention - women - cardiovascular disease - myocardial infarction
 

  • References

  • 1 Roger VL, Go AS, Lloyd-Jones DM , et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2012 update: a report from the American Heart Association. Circulation 2012; 125 (1) e2-e220
    CrossrefPubMedGoogle Scholar
  • 2 Mosca L, Hammond G, Mochari-Greenberger H, Towfighi A, Albert MA ; American Heart Association Cardiovascular Disease and Stroke in Women and Special Populations Committee of the Council on Clinical Cardiology, Council on Epidemiology and Prevention, Council on Cardiovascular Nursing, Council on High Bloo. Fifteen-year trends in awareness of heart disease in women: results of a 2012 American Heart Association national survey. Circulation 2013; 127 (11) 1254-1263 , e1–e29
    CrossrefPubMedGoogle Scholar
  • 3 Ford ES, Ajani UA, Croft JB , et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007; 356 (23) 2388-2398
    CrossrefPubMedGoogle Scholar
  • 4 Mosca L, Grundy SM, Judelson D , et al. Guide to preventive cardiology for women. AHA/ACC Scientific Statement Consensus panel statement. Circulation 1999; 99 (18) 2480-2484
    CrossrefPubMedGoogle Scholar
  • 5 Mosca L, Appel LJ, Benjamin EJ , et al; American Heart Association. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation 2004; 109 (5) 672-693
    CrossrefPubMedGoogle Scholar
  • 6 Mosca L, Banka CL, Benjamin EJ , et al; Expert Panel/Writing Group; American Heart Association; American Academy of Family Physicians; American College of Obstetricians and Gynecologists; American College of Cardiology Foundation; Society of Thoracic Surgeons; American Medical Women's Association; Centers for Disease Control and Prevention; Office of Research on Women's Health; Association of Black Cardiologists; American College of Physicians; World Heart Federation; National Heart, Lung, and Blood Institute; American College of Nurse Practitioners. Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update. Circulation 2007; 115 (11) 1481-1501
    CrossrefPubMedGoogle Scholar
  • 7 Mosca L, Benjamin EJ, Berra K , et al; American Heart Association. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update: a guideline from the American Heart Association. J Am Coll Cardiol 2011; 57 (12) 1404-1423
    CrossrefPubMedGoogle Scholar
  • 8 Wassertheil-Smoller S, Hendrix SL, Limacher M , et al; WHI Investigators. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial. JAMA 2003; 289 (20) 2673-2684
    CrossrefPubMedGoogle Scholar
  • 9 Hendrix SL, Wassertheil-Smoller S, Johnson KC , et al; WHI Investigators. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 2006; 113 (20) 2425-2434
    CrossrefPubMedGoogle Scholar
  • 10 Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998; 97 (18) 1837-1847
    CrossrefPubMedGoogle Scholar
  • 11 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285 (19) 2486-2497
    CrossrefPubMedGoogle Scholar
  • 12 Khot UN, Khot MB, Bajzer CT , et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 2003; 290 (7) 898-904
    CrossrefPubMedGoogle Scholar
  • 13 Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA 2007; 297 (6) 611-619
    CrossrefPubMedGoogle Scholar
  • 14 Kim HC, Greenland P, Rossouw JE , et al. Multimarker prediction of coronary heart disease risk: the Women's Health Initiative. J Am Coll Cardiol 2010; 55 (19) 2080-2091
    CrossrefPubMedGoogle Scholar
  • 15 Conroy RM, Pyörälä K, Fitzgerald AP , et al; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24 (11) 987-1003
    CrossrefPubMedGoogle Scholar
  • 16 Perk J, De Backer G, Gohlke H , et al; European Association for Cardiovascular Prevention & Rehabilitation (EACPR); ESC Committee for Practice Guidelines (CPG). European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 2012; 33 (13) 1635-1701
    CrossrefPubMedGoogle Scholar
  • 17 Howard BV, Van Horn L, Hsia J , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295 (6) 655-666
    CrossrefPubMedGoogle Scholar
  • 18 Prentice RL, Caan B, Chlebowski RT , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295 (6) 629-642
    CrossrefPubMedGoogle Scholar
  • 19 Beresford SA, Johnson KC, Ritenbaugh C , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006; 295 (6) 643-654
    CrossrefPubMedGoogle Scholar
  • 20 de Lorgeril M, Renaud S, Mamelle N , et al. Mediterranean alpha-linolenic acid-rich diet in secondary prevention of coronary heart disease. Lancet 1994; 343 (8911) 1454-1459
    CrossrefPubMedGoogle Scholar
  • 21 de Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99 (6) 779-785
    CrossrefPubMedGoogle Scholar
  • 22 Estruch R, Ros E, Salas-Salvadó J , et al; PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368 (14) 1279-1290
    CrossrefPubMedGoogle Scholar
  • 23 Wu T, Gao X, Chen M, van Dam RM. Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: a meta-analysis. Obes Rev 2009; 10 (3) 313-323
    CrossrefPubMedGoogle Scholar
  • 24 Chobanian AV, Bakris GL, Black HR , et al; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289 (19) 2560-2572
    CrossrefPubMedGoogle Scholar
  • 25 Smith SM, Gong Y, Turner ST , et al. Blood pressure responses and metabolic effects of hydrochlorothiazide and atenolol. Am J Hypertens 2012; 25 (3) 359-365
    CrossrefPubMedGoogle Scholar
  • 26 Cooper-DeHoff RM, Egelund EF, Pepine CJ. Blood pressure lowering in patients with diabetes—one level might not fit all. Nat Rev Cardiol 2011; 8 (1) 42-49
    CrossrefPubMedGoogle Scholar
  • 27 Ray KK, Seshasai SR, Erqou S , et al. Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med 2010; 170 (12) 1024-1031
    CrossrefPubMedGoogle Scholar
  • 28 Culver AL, Ockene IS, Balasubramanian R , et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med 2012; 172 (2) 144-152
    CrossrefPubMedGoogle Scholar
  • 29 Rivera CM, Song J, Copeland L, Buirge C, Ory M, McNeal CJ. Underuse of aspirin for primary and secondary prevention of cardiovascular disease events in women. J Womens Health (Larchmt) 2012; 21 (4) 379-387
    CrossrefPubMedGoogle Scholar
  • 30 Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006; 295 (3) 306-313
    CrossrefPubMedGoogle Scholar
  • 31 Ridker PM, Cook NR, Lee IM , et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352 (13) 1293-1304
    CrossrefPubMedGoogle Scholar
  • 32 Park K, Bavry AA. Aspirin: its risks, benefits, and optimal use in preventing cardiovascular events. Cleve Clin J Med 2013; 80 (5) 318-326
    CrossrefPubMedGoogle Scholar
  • 33 US Preventive Services Task Force. Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2009; 150 (6) 396-404
    CrossrefPubMedGoogle Scholar
  • 34 Rossouw JE, Anderson GL, Prentice RL , et al; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002; 288 (3) 321-333
    CrossrefPubMedGoogle Scholar
  • 35 Anderson GL, Limacher M, Assaf AR , et al; Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291 (14) 1701-1712
    CrossrefPubMedGoogle Scholar
  • 36 Moyer VA ; U.S. Preventive Services Task Force. Menopausal hormone therapy for the primary prevention of chronic conditions: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2013; 158 (1) 47-54
    CrossrefPubMedGoogle Scholar
  • 37 Albert CM, Cook NR, Gaziano JM , et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA 2008; 299 (17) 2027-2036
    CrossrefPubMedGoogle Scholar